Dexamethasone induces pancreatic β-cell apoptosis through upregulation of TRAIL death receptor

in Journal of Molecular Endocrinology
View More View Less
  • 1 K Suksri, Department of Physiology, Faculty of Medicine, Siriraj Hospital, Mahidol University, Bangkoknoi, 10700, Thailand
  • 2 N Semprasert, Physiology, Faculty of Medicine Siriraj Hospital, Mahidol University, 2 prannok, bangkoknoi, Thailand
  • 3 M Junking, Department of Research and Development (Division of Molecular Medicine), Faculty of Medicine Siriraj Hospital, Mahidol University, 2 prannok, bangkoknoi, Thailand
  • 4 S Kutpruek, Physiology, Mahidol University Faculty of Medicine Siriraj Hospital, 2 prannok, bangkoknoi, Thailand
  • 5 T Limjindaporn, Anatomy, Faculty of Medicine Siriraj Hospital, Mahidol University, Physiology, 2 prannok, bangkoknoi, Thailand
  • 6 P Yenchitsomanus, Department of Research and Development (Division of Molecular Medicine), Faculty of Medicine Siriraj Hospital, Mahidol University, Bangkok, Thailand
  • 7 S Kooptiwut, Physiology, Faculty of Medicine Siriraj Hospital, Mahidol University, 2 prannok, bangkoknoi, Thailand

Correspondence: Suwattanee Kooptiwut, Email: S_kooptiwut@hotmail.com

Long-term medication with dexamethasone (a synthetic glucocorticoid (GC) drug) results in hyperglycemia, or steroid-induced diabetes. Although recent studies revealed dexamethasone directly induces pancreatic β-cell apoptosis, its molecular mechanisms remain unclear. In our initial analysis of mRNA transcripts, we discovered the tumor necrosis factor-related apoptosis-inducing ligand (TRAIL) pathway may be involved in dexamethasone-induced pancreatic β-cell apoptosis. In the present study, a mechanism of dexamethasone-induced pancreatic β-cell apoptosis through the TRAIL pathway was investigated in cultured cells and isolated mouse islets. INS-1 cells were cultured with and without dexamethasone in the presence or absence of a glucocorticoid receptor (GR) inhibitor, RU486. We found that dexamethasone induced pancreatic β-cell apoptosis in association with the upregulation of TRAIL mRNA and protein expression. Moreover, dexamethasone upregulated the TRAIL death receptor (DR5) protein but suppressed the decoy receptor (DcR1) protein. Similar findings were observed in mouse isolated islets: dexamethasone increased TRAIL and DR5 compared to that of control mice. Furthermore, dexamethasone stimulated pro-apoptotic signaling including superoxide production, caspase-8, -9, and -3 activities, NF-B, and Bax, but repressed the anti-apoptotic protein, Bcl-2. All these effects were inhibited by the GR-inhibitor, RU486. Furthermore, knock down DR5 decreased dexamethasone-induced caspase 3 activity. Caspase-8 and caspase-9 inhibitors protected pancreatic β-cells from dexamethasone-induced apoptosis. Taken together, dexamethasone induced pancreatic β-cell apoptosis by binding to the GR and inducing DR5 and TRAIL pathway.

 

Society for Endocrinology

Sept 2018 onwards Past Year Past 30 Days
Abstract Views 307 307 307
Full Text Views 10 10 10
PDF Downloads 15 15 15